December 17, 2020 - 12 to 1 p.m.
Dr. Tanya Uritsky, clinical pharmacy specialist in pain stewardship at the Hospital of the University of Pennsylvania
Join Dr. Tanya Uritsky, clinical pharmacy specialist in pain
stewardship at the Hospital of the University of Pennsylvania, where she will
identify risk factors for opioid-induced respiratory depression in hospitalized
surgical patients, define opioid tolerance, recognize other CNS depressants
that can potentiate opioid-induced sedation and respiratory depression, and
recommend an appropriate opioid starting dose for an opioid naïve perioperative
Opioid stewardship is the appropriate use of opioids and is
an important part of patient safety. The highest risk for the development of
opioid-induced respiratory depression is during the first 24 hours
post-operatively. Knowing the best practices for pain management in the
perioperative period, including how to identify a patient at increased risk for
opioid-related adverse events, can help to improve patient safety. This session
will provide insights into patient-related risk factors and considerations for
pain management in the perioperative period.
To view the webinar recording, please visit the Patient Safety Authority's YouTube channel at: https://www.youtube.com/watch?v=CcFYMgtLh7w
In support of improving patient care, this activity has been
planned and implemented by Amedco LLC and PSHP. Amedco LLC is jointly
accredited by the Accreditation Council for Continuing Medical Education
(ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide continuing education
for the healthcare team.
Pharmacists and Pharmacy Technicians (ACPE):
Amedco LLC designates this activity for a maximum of 1.00
knowledge-based CPE contact hours comprised of the following topic designator:
08 – Pain Management.